Home/Investors/Information not publicly available

Information not publicly available

Biotech Investor · 9 portfolio companies

Portfolio

9

Focus Areas

6

Top Stage

preclinical

Investment Focus

Infectious Diseases Cardiovascular Oncology Genetic Disorders Immunology Metabolic

Portfolio Companies

Company	Stage	Valuation	Focus
ZiJian Biotechnology	commercial	—	Infectious Diseases, Cardiovascular
Visirna Therapeutics	preclinical	—	Oncology, Genetic Disorders
SmartNuclide Biopharma	phase-1	—	Oncology
Sanyou Biopharmaceuticals	preclinical	—	Oncology, Immunology
OPM Biosciences	preclinical	—	Oncology, Immunology
Liveome	preclinical	—	Metabolic
DK Diagnostics	commercial	—	Infectious Diseases
Noile-Immune Biotech	preclinical	—	Oncology, Immunology
Shin Nippon Biomedical Laboratories	preclinical	—	Oncology